Jagsonpal Pharmaceuticals (JAGSNPHARM) — Corporate Action

📢 Key Event
Allotment of 27,950 shares under ESOP 2022

🔄 What Changed
Paid-up capital increased by Rs. 56,000; total shares rose by 27,950

💡 Investor Takeaway
This dilutes existing shareholders' ownership proportionally through new share issuance.

Jagsonpal Pharmaceuticals allotted 27,950 equity shares of Rs. 2 each under its 2022 Employee Stock Option Plan on August 24, 2026, increasing paid-up capital from Rs. 13,18,58,940 to Rs. 13,19,14,840 and total shares from 6,59,29,470 to 6,59,57,420, with shares ranking pari passu with existing shares.

📄 View Original Announcement (PDF)

📊 Stock Analysis — JAGSNPHARM ✨ Ask AI About This

About Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,586.96 Cr P/E: 35.5 ROE: 19.0% ROCE: 25.8% Div Yield: 1.66%

View full JAGSNPHARM stock details →

📡 Get AI alerts when JAGSNPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JAGSNPHARM — Free

💡 Ask AI about this filing

"How does this ESOP issuance affect EPS?" "What is the current market price of JAGSNPHARM shares?" "How many shares remain available under the ESOP 2022 plan?"

Ask AI Free →

📊 More JAGSNPHARM filings

See all JAGSNPHARM filings →

🔥 Also filed on 24 August 2026

BALAJITELE Balaji Telefilms Limited Corporate Action PATINTLOG Patel Integrated Logistics Limited Corporate Action SKIL SKIL Infrastructure Limited Announcement RHL Robust Hotels Limited Annual Report AAVAS Aavas Financiers Limited Annual Report CTE Cambridge Technology Enterprises Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JAGSNPHARM files new disclosures

Track JAGSNPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JAGSNPHARM — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd